University of Manchester, Manchester, UK
University of Manchester, Manchester, UK.
Clin Med (Lond). 2021 Mar;21(2):107-113. doi: 10.7861/clinmed.2020-0582.
Iron deficiency anaemia (IDA) currently affects 1.2 billion people and iron deficiency without anaemia (IDWA) is at least twice as common. IDWA is poorly recognised by clinicians despite its high prevalence, probably because of suboptimal screening recommendations. Diagnosing IDWA relies on a combination of tests, including haemoglobin and ferritin levels, as well as transferrin saturation. Although the causes of iron deficiency may sometimes be obvious, many tend to be overlooked. Iron sufficiency throughout pregnancy is necessary for maternal and foetal health. Preoperative IDWA must be corrected to reduce the risk of transfusion and postoperative anaemia. Oral iron is the first-line treatment for managing IDWA; however, intravenous supplementation should be used in chronic inflammatory conditions and when oral therapy is poorly tolerated or ineffective. This review considers the causes and clinical features of IDWA, calls for greater awareness of the condition, and proposes diagnostic and management algorithms.
缺铁性贫血(IDA)目前影响着 12 亿人,而无贫血缺铁症(IDWA)的发病率至少是其两倍。尽管 IDWA 很常见,但由于筛查建议不够完善,临床医生往往对此认识不足。诊断 IDWA 需要结合多种检查,包括血红蛋白和铁蛋白水平以及转铁蛋白饱和度。虽然缺铁的原因有时可能很明显,但许多原因往往容易被忽视。妊娠期间铁充足对于母婴健康都很必要。术前 IDWA 必须得到纠正,以降低输血和术后贫血的风险。口服铁剂是治疗 IDWA 的一线药物;然而,在慢性炎症状态下以及口服治疗不耐受或无效时,应使用静脉补充剂。本综述考虑了 IDWA 的病因和临床特征,呼吁提高对该病的认识,并提出了诊断和治疗的算法。